Cargando…

MON-512 The Anti-Cancer Agent, Homoharringtonine, Induces the Sodium Iodide Symporter (NIS) Gene Expression in Culture Cells from Papillary Thyroid Cancer, as Well as Non-Thyroid Cancers

BACKGROUND: The therapeutic effect of thyroid cancer by radioiodide treatment is dependent on enhancement of NIS expression by TSH, especially its much greater magnitude in target tissue(s) compared to other healthy tissues. We preliminarily found that a protein synthesis inhibitor cycloheximide (CH...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kato, Kanako
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Thyroid
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208872/ http://dx.doi.org/10.1210/jendso/bvaa046.582

Ejemplares similares

OR14-05 Taking Advantage Of The Interleukin-6-Biology In Differentiated Thyroid Cancer To Stimulate Sodium Iodide Symporter (NIS)-mediated Iodide Uptake In Engineered Mesenchymal Stem Cells
por: Florentine Koehler, Viktoria, et al.
Publicado: (2023)

Induction of Sodium/Iodide Symporter (NIS) Expression and Radioiodine Uptake in Non-Thyroid Cancer Cells
por: Liu, Zhi, et al.
Publicado: (2012)

Effect of thyroid statuses on sodium/iodide symporter (NIS) gene expression in the extrathyroidal tissues in mice
por: Harun-Or-Rashid, et al.
Publicado: (2010)

MON-486 Polygenic Susceptibility to Papillary Thyroid Cancer in Italian Subjects
por: Brigante, Giulia, et al.
Publicado: (2020)

Dimerization of the Sodium/Iodide Symporter
por: Thompson, Rebecca J., et al.
Publicado: (2019)

Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer
por: Micali, Salvatore, et al.
Publicado: (2014)

MON-455 Papillary Thyroid Carcinoma in the Thyroglossal Duct
por: Franco, Katty Manrique, et al.
Publicado: (2020)

MON-508 Clinicopathological Features of Papillary Thyroid Cancer After Fukushima and Chernobyl Accidents
por: Drozd, Valentina, et al.
Publicado: (2020)

MON-439 Graves’ Disease and Papillary Thyroid Cancer: A Rare Clinical Case?
por: Volkova, Natalia, et al.
Publicado: (2020)

SAT512 Familial Thyroid Cancer With Negative Pre-operative Genetic Screening
por: Yuen, Alexa, et al.
Publicado: (2023)

MON-489 Comorbidity of Primary Hyperparathyroidism and Papillary Thyroid Cancer. A Single Center Outcomes
por: Papadopoulou, Nektaria, et al.
Publicado: (2020)

MON-456 Clinical Profile of Thyroid Papillary Microcarcinoma in Brazil
por: Diniz, Bruna Dellatorre, et al.
Publicado: (2020)

Taking Advantage of the TGFB1 Biology in Differentiated Thyroid Cancer to Stimulate Sodium Iodide Symporter (NIS)-Mediated Iodide Uptake in Engineered Mesenchymal Stem Cells
por: Han, Yang, et al.
Publicado: (2021)

Thyroid Hormone Resistance With Concurrent Papillary Thyroid Cancer
por: Pahwa, Dhivya, et al.
Publicado: (2021)

MON-574 Predicting the Risk of Thyroid Cancer with Sonographic Patterns of Thyroid Macrocalcifications
por: Reznick, Tanya, et al.
Publicado: (2019)

MON-495 Influence of Lymphocytic Thyroiditis at Histology and Serum Thyroglobulin Autoantibodies on the Course of Papillary Thyroid Carcinoma
por: Viola, Nicola, et al.
Publicado: (2020)

Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS
por: Oh, Ji Min, et al.
Publicado: (2021)

MON-LB82 Plasma Expression Level of MiRNA -21 Is Related With the Presence of Papillary Thyroid Cancer
por: Zilaitiene, Birute, et al.
Publicado: (2020)

MON-532 Characterization of the Angiogenic Factor SFRP2 in Papillary Thyroid Carcinoma
por: Wofford, Wyatt O, et al.
Publicado: (2020)

MON-442 Tall Cell Variant of Papillary Thyroid Carcinoma Presenting Acutely as a Right Thyroid Mass and Thyroiditis - an Unusual Presentation
por: Goyal, Itivrita, et al.
Publicado: (2020)

Propensity Score-Matched Analysis to Identify Pathways Associated with Loss of Sodium Iodide Symporter in Papillary Thyroid Cancer
por: Lee, Fang, et al.
Publicado: (2022)

MON-533 Diffuse Sclerosing Variant Papillary Thyroid Cancer: Clinical and Histopathological Features, Mutational Profile, Management and Outcome
por: Aljomaiah, Abeer Abdulhadi, et al.
Publicado: (2020)

MON-524 Prospective Evaluation of Patients with Encapsulated Classical Variant of Papillary Thyroid Cancer and Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Have They A Similar Prognosis?
por: Giani, Carlotta, et al.
Publicado: (2020)

Transcription Factor CREB3L1 Regulates the Expression of the Sodium/Iodide Symporter (NIS) in Rat Thyroid Follicular Cells
por: Di Giusto, Pablo, et al.
Publicado: (2022)

MON-579 Toxic Multinodular Goiter And Thyroid Cancer Risk
por: Kampe-Okotie, Doris, et al.
Publicado: (2019)

MON-488 Technologies of Diffuse Optics in the Diagnosis of Thyroid Cancer
por: Velazquez, Gloria Beatriz Aranda, et al.
Publicado: (2020)

MON-436 Cribriform-morular Variant of Papillary Thyroid Carcinoma: A Case Report
por: Shaheen, Zainab, et al.
Publicado: (2020)

MON-536 SPOCK1 Promotes the Progression of Papillary Thyroid Cancer ViaPI3K/Akt Signaling Activation
por: Li, Hai, et al.
Publicado: (2020)

ODP512 Renal Cell Carcinoma Metastatic to Thyroid: A Case Report
por: XU, Shiming, et al.
Publicado: (2022)

SUN-624 Occurrence Of Papillary Thyroid Cancer During Treatment Of Thyroid Dysfunction
por: Ercan, Oya, et al.
Publicado: (2019)

MON-551 Immediate Cause Of Death In Patients With Thyroid Cancer Progression
por: Ylli, Dorina, et al.
Publicado: (2019)

MON-560 Thyroid Cancer and Iodine Nutritional Status in Asturias (Spain)
por: Riestra, María, et al.
Publicado: (2019)

The Sodium Iodide Symporter (NIS) as an Imaging Reporter for Gene, Viral, and Cell-based Therapies
por: Penheiter, Alan R, et al.
Publicado: (2012)

Glycosylation of Sodium/Iodide Symporter (NIS) Regulates Its Membrane Translocation and Radioiodine Uptake
por: Chung, Taemoon, et al.
Publicado: (2015)

Selective sodium iodide symporter (NIS) genetherapy of glioblastoma mediatedby EGFR-targeted lipopolyplexes
por: Spellerberg, Rebekka, et al.
Publicado: (2021)

MON-447 Schwannoma Masquerading as Metastatic Papillary Thyroid Carcinoma in a Cervical Lymph Node
por: Kim, Stephanie, et al.
Publicado: (2020)

Redox Homeostasis in Thyroid Cancer: Implications in Na(+)/I(−) Symporter (NIS) Regulation
por: Cazarin, Juliana, et al.
Publicado: (2022)

A Probasin Promoter, Conditionally Replicating Adenovirus that Expresses the Sodium Iodide Symporter (NIS) for Radiovirotherapy of Prostate Cancer
por: Trujillo, Miguel A., et al.
Publicado: (2010)

The sodium/iodide symporter NIS is a transcriptional target of the p53-family members in liver cancer cells
por: Guerrieri, F, et al.
Publicado: (2013)

MON-506 Assessment of Quality of Life in Persons with Thyroid Cancer and Thyroid Nodules: A Single Center Experience
por: Raghunathan, Sapna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b1b3a4odptlkd8qislk0pcn0pj